Drug Trial Radar · NCT04232553
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
996
Actual
Start
Jun 22, 2020
Primary completion
Nov 28, 2024
Study completion Mar 2028
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Jan 18, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.
Conditions
- Crohn's Disease
Interventions
MirikizumabDrug
Administered Q4W
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Endoscopic Response at Week 52 (Participants Originating From AMAM Study)Time frame: Week 52
- Percentage of Participants Achieving Clinical Remission at Week 52 (Participants Originating From AMAM Study)Time frame: Week 52
Locations
322 sites in 32 countries. Site status is shown where the registry gives one.
Digestive Health Specialists
Dothan, Alabama
Research Solutions of Arizona
Litchfield Park, Arizona
Arizona Arthritis & Rheumatology Research, PLLC
Phoenix, Arizona
Care Access - Gilroy
Gilroy, California
Newport Huntington Medical Group
Huntington Beach, California
California Medical Research Associates
Northridge, California
Connecticut Clinical Research Institute
Bristol, Connecticut
Gastroenterology Consultants of Clearwater
Clearwater, Florida
Clinical Research of West Florida, Inc. (Clearwater)
Clearwater, Florida
IHS Health Research
Kissimmee, Florida
Ezy Medical Research
Miami, Florida
Care Access - Orlando
Orlando, Florida
Gastroenterology Associates of Pensacola, PA
Pensacola, Florida
Precision Clinical Research
Sunrise, Florida
USF Health
Tampa, Florida
Alliance Clinical Research of Tampa
Tampa, Florida
Digestive Healthcare of Georgia
Atlanta, Georgia
Gastrointestinal Specialists of Georgia
Marietta, Georgia
Grand Teton Research Group
Idaho Falls, Idaho
Qualmedica Research, LLC
Evansville, Indiana
Indiana University Health University Hospital
Indianapolis, Indiana
Delta Research Partners
Monroe, Louisiana
Capital Digestive Care - Chevy Chase
Chevy Chase, Maryland
Woodholme Gastroenterology Associates - Glen Burnie
Glen Burnie, Maryland
The Digestive Health Center of Michigan (DHCMI)
Chesterfield, Michigan
Revive Research Institute, Inc.
Farmington Hills, Michigan
MNGI Digestive Health - Plymouth Endoscopy Center & Clinic
Plymouth, Minnesota
Washington University Medical School
St Louis, Missouri
Care Access - Las Vegas
Las Vegas, Nevada
Holy Name Medical Center
Teaneck, New Jersey
Clinical & Translational Research Center (CTRC)
Chapel Hill, North Carolina
Carolina Digestive Diseases and Endoscopy Center
Greenville, North Carolina
Care Access - Kinston
Kinston, North Carolina
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Ohio Gastroenterology
Columbus, Ohio
Ohio State University
Hilliard, Ohio
North Shore Gastroenterology & Endoscopy Centers
Westlake, Ohio
The University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
University Gastroenterology
Providence, Rhode Island
Gastroenterology Associates of Orangeburg
Orangeburg, South Carolina
Showing 40 of 322 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.